Showing results (101-110 of 214) with videos related to
Sort By:
Pageof 22
Journal of Genetic Counseling|May 8, 2009
Reactions to and desire for prognostic testing in choroidal melanoma patientsTammy M Beran, Tara A McCannel, Annette L Stanton, et al.Experimental Hematology|January 1, 1979
Myelopoietic enhancement by immunoadjuvants: in vitro studies for their rational use in neutropenic patientsD S Verma, G Spitzer, K A Dicke, et al.Leukemia|July 30, 2003
Opportunities for Trisenox (arsenic trioxide) in the treatment of myelodysplastic syndromesA List, M Beran, J DiPersio, et al.Leukemia|October 27, 1997
Fludarabine and granulocyte colony-stimulating factor (G-CSF) in patients with chronic lymphocytic leukemiaS O'Brien, H Kantarjian, M Beran, et al.Leukemia|February 3, 1998
Cellular pharmacology of mitoxantrone in p-glycoprotein-positive and -negative human myeloid leukemic cell linesU Consoli, N T Van, N Neamati, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
Effects of signal transduction inhibitor 571 in acute myelogenous leukemia cellsB Scappini, F Onida, H M Kantarjian, et al.Folia Microbiologica|January 1, 1991
Macrotetrolide antibiotics produced by Streptomyces globisporusJ Jizba, P Sedmera, J Zima, et al.Blood|August 15, 1995
Interferon maintenance therapy for patients with chronic lymphocytic leukemia in remission after fludarabine therapyS O'Brien, H Kantarjian, M Beran, et al.Blood|January 1, 1981
Adherent cell inhibition of human leukemic in vitro agar clonal growth by short-term cell-to-cell contactG Spitzer, D S Verma, M Beran, et al.Cancer Research|February 15, 1987
In vitro toxicity and DNA cleaving capacity of benzisoquinolinedione (nafidimide; NSC 308847) in human leukemiaB S Andersson, M Beran, M Bakic, et al.Pageof 22